SEIU Healthcare Holiday Turkey Giveaway is back for 2026! - SEIU Healthcare Union
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
SEIU Healthcare Holiday Turkey Giveaway is back for 2026! As part of our Member Assistance Program, we’re once again coming together this holiday season to support one another and celebrate the strength of our union. It’s one of the ways we look out for each other, recognize the incredible work you do every day and make sure no one has to face the challenges of the season alone.
This giveaway is about more than a meal. It’s about what we can do when we come together. It’s about recognizing the strength we have in each other and building a union where every contribution matters and every member has a role to play in this new era of worker power.
This article is an excerpt. To read the full content, visit the original source. SEIU Healthcare Union
Related articles
August 3rd holiday closures at the MUHC - McGill University Health Centre
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!